Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 21, 2021

BUY
$100.84 - $161.89 $3.6 Million - $5.78 Million
35,725 Added 16616.28%
35,940 $0
Q1 2021

May 06, 2021

SELL
$110.72 - $210.04 $2,214 - $4,200
-20 Reduced 8.51%
215 $26,000
Q1 2021

May 05, 2021

BUY
$110.72 - $210.04 $26,019 - $49,359
235 New
235 $9,000

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.18B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Abundance Wealth Counselors Portfolio

Follow Abundance Wealth Counselors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abundance Wealth Counselors, based on Form 13F filings with the SEC.

News

Stay updated on Abundance Wealth Counselors with notifications on news.